Pharmacy

AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical  trial involving patients with uncontrolled or treatment-resistant hypertension.  In the trial, patients who received either 1 mg or 2 mg of baxdrostat once daily had a greater…

The FDA published a database containing more than 200 letters to pharmaceutical companies detailing why the agency initially refused to approve their products, The New York Times reported July 10.  FDA officials described the move as a form of “radical…

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA. 

FDA Commissioner Marty Makary, MD, said the agency may fast-track new drugs from pharmaceutical companies that equalize the cost of their medicines between the U.S. and other countries, Bloomberg reported July 11.  “We can issue a national priority review voucher…

In response to a growing pharmacy technician shortage and oncology care demands, Moffitt Cancer Center in Tampa, Fla., developed and launched an in-house training program to help grow its pharmacy technician workforce.  Since its inception in 2021, the program has…

While the total number of drug shortages in the U.S. appears to be decreasing in 2025, some shortages of essential medications have yet to be resolved.  Erin Fox, PharmD, senior pharmacy director at University of Utah Health, said a few…

AI and automation are everywhere, and for healthcare leaders, especially those in pharmacy, the pressure to “do more with less” has never been greater. Many teams know AI and automation solutions hold promise to increase efficiency, maximize revenue, or improve…

Kim Spencer, PharmD, St. Louis-based SSM Health’s chief pharmacy officer, has stepped down from her role.  Dr. Spencer, who built and oversaw a team of 1,400 pharmacy professionals, said in a July 7 LinkedIn that the post was “the honor…

A new analysis has challenged an earlier assessment of the severity and prevalence of withdrawal symptoms following antidepressant use, sparking a renewed debate over long-term mental health treatment strategies.  The review, published July 9 in JAMA Psychiatry, included more than…

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease.  The update introduces a gradual titration schedule aimed at reducing risk of amyloid-related…